Chinese clinical scientist Wang Yongjun has been granted the William M. Feinberg Award for Excellence in Clinical Stroke at the 2025 International ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors, leading to better ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 ...

Eleven scientists will be recognized for their individual exceptional professional achievements and contributions to stroke care and research during the American Stroke Association’s International ...